BioNTech’s CEO said there’s a ‘relatively high’ possibility the vaccine they made with Pfizer will protect against the UK’s new coronavirus variant

BioNTech CEO Ugur Sahin, whose company is Pfizer’s vaccine partner in Europe, told reporters on